ESR1 and prostate carcinoma: Our results showed that AICAR has more inhibitory effect in CRPC cells (22Rv1 and PC3) than androgen-dependent prostate cancer cells (LNCaP and C4-2), suggesting that inhibitory effect of AICAR might be associated with the activity of the ER-mediated signaling axis.